Hull E. M. Effects of neonatal exposure to progesterone in sexual behavior of male and female rats. Physiol. Behav., 1981; 26:401–405.
IARC (International Agency for Research on Cancer). Overall evaluation of carcinogenicity: an updating of IARC monographs volumes 1–42: Progestins; combined oral contraceptives. Suppl. 7. Albany, NY: WHO Publications Centre USA, 1987.
Iftikhar S., et al. Use of bioidentical hormones for menopausal concerns: cross sectional survey in an academic menopause center. J. Women s Health, 2011; 20:559–565.
Igarashi M. Augmentive effect of ascorbic acid upon induction of human ovulation in clomiphene-ineffective anovulatory women. Int. J. Fertil., 1977; 22:168–173.
Ikka T., Kawashima K. Studies on the virilizing activities of synthetic hormones in female rat fetuses: IV. Synergic effect of estrogens on the vrilizing activity of gestagens. Congen Anomalies, 2001; 41:269.
IngamellsIain S., Cameron I. T. Disorders of ovulation. Women’s Health Medicine, 2006; 3:3:109–112.
Inoue T., et al. Spatial and topological distribution of progesterone receptor A and B isoforms during human development. Mol. Cell. Endocrinol., 2001; 182:83–89.
Insler V. Corpus luteum defects. Curr. Opin. Obstet. Gynecol., 1992; 4:203–211.
Isaacs J. D., Whitworth N. S., Cowan B. D. Relative operating characteristic analysis in reproductive medicine: comparison of progesterone and human chorionic gonadotropin doubling time as predictors of early gestational normalcy. Fertil. Steril., 1994; 62:452–445.
Ishikawa H., et al. Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma. Endocrinol., 2010; 151 (6):2433–2442.
Israel R., et al. Single luteal phase serum progesterone assay as an indicator of ovulation. Am. J. Obstet. Gynecol., 1972; 112:1043–1046.
Jabbour H. N., Critchley H. O. Potential roles of decidual prolactin in early pregnancy. Reproduction, 2001; 121:197–205.
Jabbour H. N., et al. Endocrine Regulation of Menstruation. Critchley Endocrine Reviews, 2006; 27 (1):17–46.
Jacob A., et al. Human sperm non-nuclear progesterone receptor expression is a novel marker for fertilization outcome. Mol. Hum. Reprod., 1998; 4:533–542.
Jacobsen B. M., Horwitz K. B. Progesterone receptors, their isoforms and progesterone regulated transcription. Molecular and Cellular Endocrinology, 2012; 357:18–29.
Jaiswal B. S., Eisenbach M. Capacitation. In: Hardy D. M., ed. Fertilization. San Diego: Academic Press, 2002; 57–117.
Jamain M. & Grenet C. Utilization of 6-dehydro-retroprogesterone in obstetrics: indications; results. Bull. Fed. Soc. Gynecol. Obstet. Lang. Fr., 1969; 21:26–31.
James A., Matchar D. B., Myers E. R. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet. Gynecol., 2004; 104:381–388.
James W. J. Women’s hormone concentrations and the increasing rates of ectopic pregnancy. Hum. Reprod., 1996; 11:233–235.
Janeczko A., Skoczowski A. Mammalian sex hormones in plants. Folia Histochem. Cytobiol., 2005; 43 (2):71–79.
Jemal A., et al.Global cancer statistics. CA Cancer J. Clin., 2011; 61:69–90.
Jenkins R. L., et al. Androstenedione and progesterone in the sediment of a river receiving paper mill effluent. Toxicol. Sci., 2003; 73:53–59.
Jensen M. B., Publicover S. J. Progesterone and CatSper dependency. International Journal of Andrology, 2012; 35:631–632.
Jerry D. J. Roles for estrogen and progesterone in breast cancer prevention. Breast Cancer Res., 2007; 9:102.
Jin M., et al. Most fertilizing mouse spermatozoa begin their acrosome reaction before contact with the zona pellucida during in vitro fertilization. Proc. Natl. Acad. Sci. USA, 2011; 108:4892–4896.
Joachim R., et al. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids, 2003; 68:931–940.
Johnson M. H., Everitt B. J. Adult ovarian function. In Essential Reproduction. Oxford: Blackwell Science, 2000; 5:74–75.
Johnson W. S., Gravestock M. B., McCarry B. E. Acetylenic bond participation in biogenic like olefinic cyclizations. II. Synthesis of dl-Progesterone. JACS, 1971; 4332–4334.
Jones H. W. Jr., Wilkins L. The genital anomaly associated with prenatal exposure to progestogens. Fertil. Steril., 1960; 11:148–156.
Jones L. A., Bern H. A. Cervicovaginal and mammary gland abnormalities in BALB/cCrgl mice treated neonatally with progesterone and estrogen, alone or in combination. Cancer Res., 1979; 39:2560–2567.
Jones L. A., Bern H. A. Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice. Cancer Res., 1977; 37:67–75.
Jones L. A., et al. Prevention by progesterone of cervicovaginal lesions in neonatally estrogenized BALB/c mice. Cancer Lett., 1984; 23:123–128.
Jordan V. C. Long-term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Research and Treatment, 1990; 15:125–136.